Trial Profile
Clinical Trials Insight: 700020518
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 24 Jan 2007
Price :
$35
*
At a glance
- Drugs Paclitaxel poliglumex (Primary)
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Sponsors Cell Therapeutics
- 24 Jan 2007 New trial record.